Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization

View through CrossRef
Hydrogel is one of the most interesting and excellent candidates for oral drug delivery. The current study focuses on formulation development of hydrogels for controlled oral delivery of esomeprazole. The hydrogels were prepared by solution casting method by dissolving polymers in Polyvinyl alcohol (PVA) solution. Calcium alginate, Hydroxyl propyl methylcellulose (HPMC), acrylic acid and chondroitin sulfate were used in the preparation of hydrogels. Fourier transform infrared (FTIR) analysis showed no incompatibilities between drug and excipients used in the preparation of formulations. The hydrogels were characterized for size and surface morphology. Drug encapsulation efficiency was measured by Ultraviolet-visible (UV-VIS) spectroscopy. In vitro release studies were carried out using dissolution apparatus. The formulated hydrogels were then compared with the marketed product in vivo using rabbits. The result indicates that prepared hydrogels have a uniform size with a porous surface. The esomeprazole encapsulation efficiency of the prepared hydrogels was found to be 83.1 ± 2.16%. The esomeprazole-loaded hydrogel formulations showed optimum and Pharmacopeial acceptable range swelling behavior. The release of esomeprazole is controlled for 24 h (85.43 ± 0.32% in 24 h). The swelling and release of drug results make the prepared hydrogels a potential candidate for the controlled delivery of esomeprazole. The release of the drug from prepared hydrogel followed the super case transport-2 mechanism. The in vivo studies showed that prepared hydrogel formulations showed controlled and prolonged release of esomeprazole as compared to drug solution and marketed product. The formulations were kept for stability studies; there was no significant change observed in physical parameters, i.e., (appearance, color change and grittiness) at 40 °C ± 2/75% ± RH. There was a negligible difference in the drug content observed after the stability study suggested that all the formulations are stable under the given conditions for 60 days. The current study provides a valuable perspective on the controlled release profile of Hydroxyl propyl methylcellulose (HPMC) and calcium alginate-based esomeprazole hydrogels.
Title: Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization
Description:
Hydrogel is one of the most interesting and excellent candidates for oral drug delivery.
The current study focuses on formulation development of hydrogels for controlled oral delivery of esomeprazole.
The hydrogels were prepared by solution casting method by dissolving polymers in Polyvinyl alcohol (PVA) solution.
Calcium alginate, Hydroxyl propyl methylcellulose (HPMC), acrylic acid and chondroitin sulfate were used in the preparation of hydrogels.
Fourier transform infrared (FTIR) analysis showed no incompatibilities between drug and excipients used in the preparation of formulations.
The hydrogels were characterized for size and surface morphology.
Drug encapsulation efficiency was measured by Ultraviolet-visible (UV-VIS) spectroscopy.
In vitro release studies were carried out using dissolution apparatus.
The formulated hydrogels were then compared with the marketed product in vivo using rabbits.
The result indicates that prepared hydrogels have a uniform size with a porous surface.
The esomeprazole encapsulation efficiency of the prepared hydrogels was found to be 83.
1 ± 2.
16%.
The esomeprazole-loaded hydrogel formulations showed optimum and Pharmacopeial acceptable range swelling behavior.
The release of esomeprazole is controlled for 24 h (85.
43 ± 0.
32% in 24 h).
The swelling and release of drug results make the prepared hydrogels a potential candidate for the controlled delivery of esomeprazole.
The release of the drug from prepared hydrogel followed the super case transport-2 mechanism.
The in vivo studies showed that prepared hydrogel formulations showed controlled and prolonged release of esomeprazole as compared to drug solution and marketed product.
The formulations were kept for stability studies; there was no significant change observed in physical parameters, i.
e.
, (appearance, color change and grittiness) at 40 °C ± 2/75% ± RH.
There was a negligible difference in the drug content observed after the stability study suggested that all the formulations are stable under the given conditions for 60 days.
The current study provides a valuable perspective on the controlled release profile of Hydroxyl propyl methylcellulose (HPMC) and calcium alginate-based esomeprazole hydrogels.

Related Results

Comparative Study of the Mechanical Properties of New PEGSSDA Hydrogels, and Their Effect on Embedded Stem Cell Secretome
Comparative Study of the Mechanical Properties of New PEGSSDA Hydrogels, and Their Effect on Embedded Stem Cell Secretome
Hydrogels are hyaluronic acid and collagen‐based polymer networks that mimic the 3D cell microenvironment and can be used as tissue‐engineered scaffolds for therapeutic delivery of...
Oral Drug Absorption and Drug Disposition in Critically Ill Cardiac Patients
Oral Drug Absorption and Drug Disposition in Critically Ill Cardiac Patients
(1) Background: In critically ill cardiac patients, parenteral and enteral food and drug administration routes may be used. However, it is not well known how drug absorption and me...
Polymeric Hydrogels As Drug Delivery Vehicles
Polymeric Hydrogels As Drug Delivery Vehicles
Polymeric hydrogels are promising polymeric functional materials that have been widely used in the biomedical field as an emerging carrier of various therapeutic agents. Polymeric ...
A Multinational Randomized Trial of Mega-Dose Esomeprazole as Anti-Inflammatory Agent in Sepsis
A Multinational Randomized Trial of Mega-Dose Esomeprazole as Anti-Inflammatory Agent in Sepsis
OBJECTIVES: Proton pump inhibitors have dose-dependent immunomodulatory effects. We tested the hypothesis that mega-dose esomeprazole therapy would reduce organ dysfunc...
Esomeprazole-Induced Central Fever with Severe Myalgia
Esomeprazole-Induced Central Fever with Severe Myalgia
OBJECTIVE: To report a case of central fever associated with severe myalgia following esomeprazole. CA...
In Vitro and In Vivo Therapeutics of Double‐Layered Hydrogels
In Vitro and In Vivo Therapeutics of Double‐Layered Hydrogels
AbstractDouble‐layered hydrogels are organized into different nanostructured layers and are the preferred material for various in vitro and in vivo therapeutic applications. Hydrog...
Investigating the Mesoscale of β-lactoglobulin Fibril Hydrogels
Investigating the Mesoscale of β-lactoglobulin Fibril Hydrogels
<p><b>The objective of this doctoral thesis was to investigate the relationship between the architecture of protein fibril networks and their macroscopic properties. Th...

Back to Top